CHARLOTTESVILLE, Virginia, December 17 /PRNewswire/ — Biovista Inc. today announced the signing of a contract with Novus Biologicals for access to Biovista’s BEA literature mining platform. BEA will be used to power Novus Explorer, a new service that Novus Biologicals is offering to visitors of its web site. Driven by BEA, Novus Explorer will allow … Read More
Year: 2009
Biovista Inc. Named Top Innovator in Life Sciences
CHARLOTTESVILLE, Virginia, December 16 /PRNewswire/ — Biovista Inc. today announced that it was awarded the 2009 Top Innovator Presentation Award in Healthcare, at the 2009 New England Venture Summit, held on December 8th at Dedham, MA. The award, which recognizes cutting edge private companies driving the future of innovation, was granted to Biovista who competed … Read More
TIF awards contract to Biovista for the installation of the JAnaemia patient record management system
CHARLOTTESVILLE, Virginia and ATHENS, Greeece, December 1 /PRNewswire/ — Biovista Inc. today announced the signing of a new collaboration agreement with the Thalassaemia International Federation (TIF) for the installation and support of its JAnaemia patient record management system. JAnaemia, which has been customized, in this case for beta thalassaemia patients, will be initially installed at … Read More
BioWorld: Strong at the Broken Places: Models for Industry’s Future
By Trista Morrison, BioWorld Insight BioVista: Artificial Intelligence for Discovery What happens when you combine the vision of Anadys Pharmaceuticals Inc…You get BioVista Inc., a start-up with a drug profiling platform that goes way beyond data mining to identify new uses for existing compounds…BioVista also has generated an internal pipeline comprising more than 30 repurposed … Read More
Biovista to present at the Life Sciences and Healthcare Venture Summit
Charlottesville, Oct 10, 2009/ Biovista announced today that its President Dr. Aris Persidis will present at the Life Sciences and Healthcare Venture Summit being held on October 27th, at NYC. Dr. Persidis will discuss Biovista’s repositioning program including BVA-201 for MS and BVA-601 for epilepsy. He will also provide an overview of Biovista’s business model and … Read More